MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-11-30.

Income Overview

Net Income
-$113,719
Unit: Dollar

Income Statement
2025-11-30
2025-08-31
2025-05-31
2024-11-30
Revenues
0 0* 0 -
Research and development expense
-0* 0 -
General and administrative expenses
64,002 162,286.25* 40,380 36,837
Total operating expenses
64,002 162,286.25* 40,380 36,837
Loss from operations
-64,002 -162,286.25* -40,380 -36,837
Financial (loss) income
-49,717 --19,347 2,485
Capital loss
-0* --
Capital gain (loss)
--0 -
Financial loss, net
-10,571.25* --
Net loss
-113,719 -172,857.5 -59,727 -34,352
Loss from available for sale assets
0 -0 -
Total comprehensive loss
-113,719 -172,857.5 -59,727 -34,352
Basic EPS
0 -0.001 0 -0.001
Diluted EPS
0 -0.001 0 -0.001
Basic Average Shares
732,857,211 198,239,676 42,597,394 31,111,352
Diluted Average Shares
732,857,211 198,239,676 42,597,394 31,111,352
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Total comprehensiveloss-$113,719 (-231.04%↓ Y/Y)Net loss-$113,719 (-231.04%↓ Y/Y)Loss from operations-$64,002 (-73.74%↓ Y/Y)Financial (loss) income-$49,717 (-2100.68%↓ Y/Y)Total operatingexpenses$64,002 (73.74%↑ Y/Y)General andadministrative expenses$64,002 (73.74%↑ Y/Y)

CNBX Pharmaceuticals Inc. (CNBX)

CNBX Pharmaceuticals Inc. (CNBX)